Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Policy & Legislation › IGRAs Poised to Broadly Replace Outdated Skin Test for Latent TB, But Questions Remain

IGRAs Poised to Broadly Replace Outdated Skin Test for Latent TB, But Questions Remain

Feb 16, 2017
|
Ben Butkus
Premium

NEW YORK (360Dx) – The market for interferon-gamma release assays (IGRAs) for detecting latent tuberculosis is growing rapidly in more industrialized areas of the world, a trend that is expected to continue in the wake of recently issued recommendations from a number of expert organizations and as peer-reviewed evidence for the tests' effectiveness mounts.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Apr
06
Featured Webinar

Reducing COVID-19 Infections Rates at a University Campus with Mass Screening

Sponsored by
Beckman Coulter

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.

Apr
16
Featured Webinar

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

What's Popular?

In Infectious Disease

  1. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

  2. OraSure Technologies Updates Plan for SARS-CoV-2 Antigen Self-Test

    Premium

  3. Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2

  4. Germany Approves COVID-19 Rapid Antigen Tests for Home Use

  5. Oxford Immunotec Nabs CE Mark for COVID-19 T-Cell Response Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.